Back to search

Article

Frequent Aneuploidy in Primary Human T Cells Following CRISPR-Cas9 cleavage

2021-08-20

Abstract excerpt

<h4>SUMMARY</h4> Multiple ongoing clinical trials use site-specific nucleases to disrupt T cell receptor (TCR) genes in order to allow for allogeneic T cell therapy 1–5 . In particular, the first U.S. clinical trial using CRISPR-Cas9 entailed the targeted disruption of the TCR chains and programmed cell death protein 1 (PDCD1) in T cells of refractory cancer patients 6 . Here, we used the same guide RNA sequenc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d029b80b-49bf-5d7d-9130-7f5407fd7c5a
DOI
10.1101/2021.08.20.457092
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Frequent Aneuploidy in Primary Human T Cells Following CRISPR-Cas9 cleavageDOI 10.1101/2021.08.20.457092
Select a neighboring publication to make it the new centre.